A recent human SV2A PET study using [11C]UCB-J in cohorts of MCI/AD patients and age-matched cognitively intact elderly subjects revealed significant reduction of synaptic density in the hippocampus and entorhinal cortex (44 and 27%, respectively) (Chen et al., 2018). This evidence concerns the gene SV2A and Alzheimer disease.